Lojkin et al. demonstrated that Klotho mRNA levels were reduced in most epithelial ovarian cancer (EOC) cell lines; its expression was high in normal ovaries but reduced in many high-grade papillary-serous adenocarcinomas of the ovaries, fallopian tubes, and peritoneum [124]. This evidence concerns the gene KL and ovarian carcinoma.